Inventor profile of:

John Patrick Maxwell

City:

Hingham, Massachusetts

Country:

United States

Published Applications:

34

Last publication date:

2024-10-10

Top Assignees for applications by John Patrick Maxwell

The entities that hold a legal rights for patent applications filed by inventor Maxwell John Patrick:

Recent patent applications by Maxwell John Patrick

John Patrick Maxwell from Hingham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-10
US20240336614A1
Chemistry; metallurgy

MODULATORS OF ALPHA-1 ANTITRYPSIN

#2 | 2023-10-26
US20230339915A1
Chemistry; metallurgy

MODULATORS OF ALPHA-1 ANTITRYPSIN

#3 | 2023-09-07
US20230277547A1
Human necessities

Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors

#4 | 2023-08-24
US20230265080A1
Chemistry; metallurgy

MODULATORS OF ALPHA-1 ANTITRYPSIN

#5 | 2023-05-25
US20230159580A1
Chemistry; metallurgy

PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)

#6 | 2023-05-25
US20230159521A1
Chemistry; metallurgy

1H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1H-PYRAZOLO[4,3-G]QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)

#7 | 2023-05-25
US20230159504A1
Chemistry; metallurgy

7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)

#8 | 2023-05-25
US20230159502A1
Chemistry; metallurgy

INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)

#9 | 2023-05-25
US20230157999A1
Human necessities

PYRANO[4,3-B]INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)

#10 | 2021-08-05
US20210236505A1
Human necessities

SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS

#11 | 2021-06-17
US20210179587A1
Chemistry; metallurgy

Modulators of alpha-1 antitrypsin

#12 | 2021-03-11
US20210069203A1
Human necessities

DNA-PK inhibitors

#13 | 2020-11-19
US20200361939A1
Chemistry; metallurgy

Modulators of alpha-1 antitrypsin

#14 | 2020-11-19
US20200361877A1
Chemistry; metallurgy

Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency

#15 | 2020-11-12
US20200353101A1
Human necessities

DNA-PK inhibitors

#16 | 2020-04-09
US20200109130A1
Chemistry; metallurgy

DNA-PK inhibitors

#17 | 2020-02-27
US20200062732A1
Chemistry; metallurgy

DNA-PK inhibitors

#18 | 2019-09-26
US20190290654A1
Human necessities

Substituted quinoxaline DNA-PK inhibitors

#19 | 2019-08-22
US20190255062A1
Human necessities

DNA-PK inhibitors

#20 | 2018-11-15
US20180325898A1
Human necessities

DNA-PK inhibitors

#21 | 2018-11-01
US20180311254A1
Human necessities

DNA-PK INHIBITORS

#22 | 2018-07-26
US20180208579A1
Chemistry; metallurgy

DNA-PK inhibitors

#23 | 2018-07-12
US20180193341A1
Human necessities

DNA-PK inhibitors

#24 | 2018-06-14
US20180161336A1
Human necessities

DNA-PK inhibitors

#25 | 2017-09-14
US20170258789A1
Human necessities

DNA-PK inhibitors

#26 | 2016-12-22
US20160368899A1
Chemistry; metallurgy

DNA-PK inhibitors for treatment of cancer

#27 | 2016-12-08
US20160354381A1
Human necessities

DNA-PK INHIBITORS

#28 | 2016-11-24
US20160340341A1
Chemistry; metallurgy

Substituted benzooxadiazole DNA-PK inhibitors

#29 | 2016-09-01
US20160250212A1
Human necessities

DNA-PK inhibitors and uses thereof

#30 | 2015-04-23
US20150111871A1
Chemistry; metallurgy

DNA-PK inhibitors

#31 | 2014-09-18
US20140275059A1
Chemistry; metallurgy

DNA-PK inhibitors

#32 | 2014-09-18
US20140275024A1
Chemistry; metallurgy

Substituted quinoxaline DNA-PK inhibitors

#33 | 2014-02-13
US20140045869A1
Chemistry; metallurgy

DNA-PK inhibitors

#34 | 2013-10-24
US20130281431A1
Human necessities

DNA-PK inhibitors

InventorID:

498650 ⎘